Related Experiment Video
Updated: Aug 15, 2026

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences
B Pasche1, H Ouimet, S Francis
1Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115.
Abstract:
Plasmin exposure modulates platelet aggregation responses, but a direct effect of plasmin on the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), has never been conclusively shown in a plasma milieu. To examine this issue, we incubated platelets in platelet-rich plasma with plasmin and measured the effect of this treatment on platelet aggregation, fibrinogen binding, and the structural integrity of GPIIb/IIIa. Plasmin treatment reduced maximal reversible fibrinogen binding in a dose-dependent fashion, and this reduction in binding was accompanied by a correlative reduction in the maximal rate of aggregation. Immunoblots performed with polyclonal antibodies against GPIIb/IIIa showed that GPIIIa had been cleaved by plasmin, but this cleavage was detected only after subsequent degradation of the solubilized GPIIb/IIIa with Staphylococcus aureus V8 (Glu-C) endoprotease. Peptide sequence analysis showed that cleavage occurred at the lys444-pro445 bond in the first cysteine-rich repeat domain of GPIIIa a unique proteolytic event observed only in the presence of plasma fibrinogen. These observations suggest that plasmin modifies GPIIIa by a unique proteolytic event in plasma that is dependent on fibrinogen binding and, consequently, is accompanied by significant reductions in fibrinogen binding and aggregation response.
Insights
Plasmin cleaves the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), in plasma. This modification reduces fibrinogen binding and platelet aggregation, impacting blood clotting mechanisms.
Area of Science:
- Hematology
- Biochemistry
- Molecular Biology
Background:
- Plasmin is known to affect platelet aggregation.
- The direct impact of plasmin on the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), in plasma remains unclear.
Purpose of the Study:
- To investigate the direct effect of plasmin on platelet GPIIb/IIIa in a plasma environment.
- To assess the consequences of plasmin treatment on platelet aggregation and fibrinogen binding.
Main Methods:
- Platelets were incubated with plasmin in platelet-rich plasma.
- Platelet aggregation, fibrinogen binding, and GPIIb/IIIa structural integrity were measured.
- Immunoblots and peptide sequencing were used to analyze GPIIb/IIIa cleavage.
Main Results:
- Plasmin treatment dose-dependently reduced maximal reversible fibrinogen binding and the rate of platelet aggregation.
- Plasmin cleaved GPIIIa, a subunit of GPIIb/IIIa, at the lys444-pro445 bond.
- This specific cleavage event was observed only in the presence of plasma fibrinogen.
Conclusions:
- Plasmin induces a unique proteolytic modification of GPIIb/IIIa in plasma, dependent on fibrinogen binding.
- This plasmin-mediated cleavage significantly reduces fibrinogen binding and platelet aggregation responses.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Intracellular Signaling Affects Focal Adhesions
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis

